70 results
Page 2 of 4
8-K
EX-99.1
kgtill8hcb0jie3sjoh
5 Jan 22
Departure of Directors or Certain Officers
5:00pm
424B5
dk9qpkg lbsn
21 Oct 21
Prospectus supplement for primary offering
4:26pm
8-K
EX-1.1
desu8menshhkidc
21 Oct 21
Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
4:24pm
424B5
tzh8lh24 skgr
20 Oct 21
Prospectus supplement for primary offering
4:15pm
8-K
EX-99.1
9t69xuexezn j8kiti
2 Sep 21
Crinetics Pharmaceuticals Expands Executive Team with Addition of Jeff Knight as Chief Operating Officer
5:00pm
8-K
6n8n35w9r pi9
2 Sep 21
Crinetics Pharmaceuticals Expands Executive Team with Addition of Jeff Knight as Chief Operating Officer
5:00pm
S-3ASR
EX-4.4
qnmui443qx49lidsrjo0
10 Aug 21
Automatic shelf registration
5:25pm
S-3ASR
e2c81
10 Aug 21
Automatic shelf registration
5:25pm
8-K
EX-99.1
nh0mvqvkcln
29 Jul 21
Stock Purchase Agreement
4:15pm
8-K
EX-1.1
o6tjt
8 Apr 21
Crinetics Pharmaceuticals Announces Pricing of Public Offering of Common Stock
4:09pm
424B5
haz yh1zubk8od3o09es
8 Apr 21
Prospectus supplement for primary offering
4:07pm
8-K
EX-99.1
m9j nge3e
3 Sep 20
Crinetics Pharmaceuticals Appoints Rare Disease Executive, Camille L. Bedrosian, M.D., to Board of Directors
7:35am
424B5
u7022chq 7s1
15 Apr 20
Prospectus supplement for primary offering
4:16pm
8-K
EX-1.1
43rc12c5voow1a
15 Apr 20
Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
4:06pm